Clinuvel Pharmaceuticals
CUV.AX
#6817
Rank
โ‚ฌ0.41 B
Marketcap
8,34ย โ‚ฌ
Share price
-0.91%
Change (1 day)
-9.61%
Change (1 year)

Clinuvel Pharmaceuticals (CUV.AX) - P/B ratio

P/B ratio as of November 2024 : 3.30

According to Clinuvel Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 8.651.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Clinuvel Pharmaceuticals - P/B ratio (from 2002 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.94-41.4%
2022-12-318.43-35.81%
2021-12-3113.1-21.57%
2020-12-3116.8-31.66%
2019-12-3124.517.21%
2018-12-3120.933.98%
2017-12-3115.6-18.86%
2016-12-3119.293.76%
2015-12-319.93-1.32%
2014-12-3110.1292.98%
2013-12-312.56-45.83%
2012-12-314.7368.08%
2011-12-312.81-2.13%
2010-12-312.8716.72%
2009-12-312.46138.05%
2008-12-311.03-37.18%
2007-12-311.65-84.52%
2006-12-3110.646.37%
2005-12-317.27-51.35%
2004-12-3114.934.9%
2003-12-3111.1912.42%
2002-12-311.09